CSL is an Australia-based biotechnology company that develops and commercializes novel drugs for the treatment of rare and serious diseases.
Business Model:
Revenue: $42.2B
Employees: 10,001-999,999
CSL was acquired by
Hongkong Telecom.
The acquisition happend on 2013-12-20.
Details of the transaction were not public
Address: 45 Poplar Road
City: Parkville
State: victoria
Zip: 3052
Country: AU
CSL is an Australia-based biotechnology company that develops and commercializes novel drugs for the treatment of rare and serious diseases.
Contact Phone:
Contact Email:
Listed Exchange:
Australian Securities Exchange
IPO Date:
4/1/1999
Ticker Symbol:
CSL
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
9/2019 | Denteric | Series A | 9.5M |
9/2020 | Ena Respiratory | Series A | 0 |
5/2000 | eBioinformatics | Venture Round | 0 |
9/2020 | Ena Respiratory | Series A | 0 |
9/2019 | Denteric | Series A | 0 |
5/2000 | eBioinformatics | Venture Round | 0 |
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 5/2020 | Debt | $750M | 2/2004 | Post-IPO Equity | $111M |
---|
Announced Date | Name | Price |
---|---|---|
12/2021 | Vifor Pharma | |
8/2017 | Calimmune | |
6/2017 | Wuhan Zhong Yuan Rui De Biological Products |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|